BioMimetic Therapeutics, Inc. (BMTI)

[surf1944]

1:26AM Biomimetic Therapeutics Augment Bone Graft receives positive recommendation from FDA Advisory Committee (BMTI) 9.20 : Co announces that the UFDA Orthopedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee voted 12-6 in support of the safety of Augment Bone Graft for use as an alternative to autograft in hindfoot and ankle fusion procedures. Approval of Augment Bone Graft would mark the co's entry into the $2.5 bln U.S. bone grafting marke